Nicholas Denko
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
424
Citations
12,846
Est. group size
~28
Recurring co-author estimate
Active years
40
Publishing since 1987
Nicholas Denko studies how tumors adapt to low-oxygen (hypoxic) and nutrient-poor conditions, and how these adaptations affect cancer growth and response to treatments like radiation therapy and hypoxia-targeted drugs. His work spans molecular biology techniques such as genome-wide screens, as well as imaging methods like PET scans to measure tumor oxygen levels, with applications to cancers including pancreatic and lung cancer.
Publication output was relatively low and steady from 2017-2022, then sharply increased starting in 2023, likely reflecting a surge in supplementary data records and dataset publications alongside primary research articles.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Reply to: Beyond the Score: Integrating Hypoxia Signatures Into Risk-Adapted Stereotactic Body Radiation Therapy for Early-Stage Non–Small Cell Lung Cancer
JCO Precision Oncology · 2025
- Nutrient scavenging-fueled growth in pancreatic cancer depends on caveolae-mediated endocytosis under nutrient-deprived conditions
Science Advances · 2024
- Editorial: Hypoxia and angiogenesis in cancer
Frontiers in Pharmacology · 2024
- Nutrient scavenging-fueled growth in pancreatic cancer depends on caveolae-mediated endocytosis under nutrient-deprived conditions
UNC Libraries · 2024
- Data from Pharmacologically Increased Tumor Hypoxia Can Be Measured by <sup>18</sup>F-Fluoroazomycin Arabinoside Positron Emission Tomography and Enhances Tumor Response to Hypoxic Cytotoxin PR-104
2023
- Data from Pharmacologically Increased Tumor Hypoxia Can Be Measured by <sup>18</sup>F-Fluoroazomycin Arabinoside Positron Emission Tomography and Enhances Tumor Response to Hypoxic Cytotoxin PR-104
2023
- Supplementary Data from Pharmacologically Increased Tumor Hypoxia Can Be Measured by <sup>18</sup>F-Fluoroazomycin Arabinoside Positron Emission Tomography and Enhances Tumor Response to Hypoxic Cytotoxin PR-104
2023
- Supplementary Data from Pharmacologically Increased Tumor Hypoxia Can Be Measured by <sup>18</sup>F-Fluoroazomycin Arabinoside Positron Emission Tomography and Enhances Tumor Response to Hypoxic Cytotoxin PR-104
2023
- Data from A Human Genome-Wide RNAi Screen Reveals Diverse Modulators that Mediate IRE1α–XBP1 Activation
2023
- Supplementary Figure S2 from A Human Genome-Wide RNAi Screen Reveals Diverse Modulators that Mediate IRE1α–XBP1 Activation
2023
- Supplementary Figure S4 from A Human Genome-Wide RNAi Screen Reveals Diverse Modulators that Mediate IRE1α–XBP1 Activation
2023
- Data from A Human Genome-Wide RNAi Screen Reveals Diverse Modulators that Mediate IRE1α–XBP1 Activation
2023
- Supplementary Figure S3 from A Human Genome-Wide RNAi Screen Reveals Diverse Modulators that Mediate IRE1α–XBP1 Activation
2023
- Supplementary Figure S3 from A Human Genome-Wide RNAi Screen Reveals Diverse Modulators that Mediate IRE1α–XBP1 Activation
2023
- Supplementary Figure S1 from A Human Genome-Wide RNAi Screen Reveals Diverse Modulators that Mediate IRE1α–XBP1 Activation
2023
- Cancer Research×18
- bioRxiv (Cold Spring Harbor Laboratory)×7
- Cancer Research Communications×5
- International Journal of Radiation Oncology*Biology*Physics×3
- Molecular Cancer Research×2
- Martin Benej
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Katarina Benejova
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Fouad Choueiry
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Ioanna Papandreou
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Martin Kery
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile